Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population

Clinical Microbiology and Infection

Volumn 17, Issue 5, 2011, Pages 763-768

  Bruns, A H W ^a   Oosterheert, J J ^a   Cucciolillo, M C ^a   El Moussaoui, R ^b   Groenwold, R H H ^a   Prins, J M ^b   Hoepelman, A I M ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Causes of death; Community acquired pneumonia; Comorbidity; Long term; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 79955378009     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03296.x     Document Type: Article

References (24)

1. World Health Organization. The global burden of disease: 2004 update. Available at: (last accessed 25 May 2009).
2. Macfarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; 2: 255-258.
3. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
4. Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet 1993; 342: 30-33.
5. Kaplan V, Clermont G, Griffin MF et al. Pneumonia: still the old man's friend? Arch Intern Med 2003; 163: 317-323.
6. Koivula I, Sten M, Makela PH. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 1999; 159: 1550-1555.
7. Hedlund JU, Ortqvist AB, Kalin ME, Granath F. Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax 1993; 48: 785-789.
8. Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 2008; 46: 550-556.
9. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 910-914.
10. Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine (Baltimore) 2008; 87: 329-334.
11. Yende S, Angus DC, Ali IS et al. Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 2007; 55: 518-525.
12. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37: 1617-1624.
13. Bordon J, Wiemken T, Peyrani P et al. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest 2010 [E-pub ahead of print].
14. Oosterheert JJ, Bonten MJ, Schneider MM et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ 2006; 333: 1193-1198.
15. El Moussaoui R, de Borgie CA, van den Broek P et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006; 332: 1355-1362.
16. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 1: S62-S88.
17. Schouten JA, Prins JM, Bonten M et al. Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia. Ned Tijdschr Geneeskd 2005; 149: 2495-2500.
18. Statistics Netherlands. Statline statistics Netherlands; all figures within reach. Available at: (last accessed 1 July 2009).
19. Myles PR, Hubbard RB, Gibson JE, Pogson Z, Smith CJ, McKeever TM. Pneumonia mortality in a UK general practice population cohort. Eur J Public Health 2009; 19: 521-526.
20. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115: 428-436.
21. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006; 28: 346-351.
22. Molinos L, Clemente MG, Miranda B et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 2009; 58: 417-424.
23. Sington JD, Cottrell BJ. Analysis of the sensitivity of death certificates in 440 hospital deaths: a comparison with necropsy findings. J Clin Pathol 2002; 55: 499-502.
24. Belongia EA, Shay DK. Influenza vaccine for community-acquired pneumonia. Lancet 2008; 372: 352-354.